PRN: Infectious Disease Molecular Diagnostics Market Report 2017 - At the Height of the Influenza or Flu Season, up to 6% of all U.S. Outpatient Visits Can be for Influenza-like Illness - Research and Markets

23/mag/2017 17:45:10 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Infectious Disease Molecular Diagnostics Market Report 2017 - At the Height of the Influenza or Flu Season, up to 6% of all U.S. Outpatient Visits Can be for Influenza-like Illness - Research and Markets

 
[23-May-2017]
 

DUBLIN, May 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Infectious Disease Molecular Diagnostics Market (Hepatitis, HIV/CT/NG/HPV and Other Tests)" report to their offering.

Research and Markets Logo

Infectious disease testing using molecular testing technologies exceeded 3.8 billion dollars in 2016. 

Growth is expected to be higher than the overall molecular testing market for the next five years.  This is according to Kalorama Information's latest study on the molecular microbiology/virology markets.  This category is projected to account for 60% of the global molecular diagnostics market by 2021.

The market segment is defined by test decentralization with the introduction of NAAT platforms able to be operated in hospital labs and near-patient points of care such as physician office labs (POLs) and outpatient clinics. Integrated design from sample preparation to results analysis and user friendly features are just as appealing to larger clinical labs to free up personnel. Menu expansion on integrated analyzers has been the predominant focus of competitors in molecular infectious disease diagnostics. Market share and client retention depend on the ability of one platform to perform all routine infectious disease tests.

The Molecular diagnostics market is unrivaled among the IVD markets because of its superior technologies in terms of its performance and applicability. Microarray, next-generation sequencing and development-stage isothermal amplification methods represent promising contributions to the market space.

Companies Mentioned

  • Abbott Diagnostics
  • Alere
  • Amoy Diagnostics
  • Aries Molecular System
  • Arrays
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (BD)
  • Bio-Rad Laboratories
  • Biomérieux
  • Cepheid (Danaher)
  • Clinical Assay Development
  • Covaris
  • Eiken Chemical
  • Flow Cytometry
  • Grifols
  • Histology/Cytology
  • Hologic
  • Illumina
  • Immucor
  • Janssen Diagnostics
  • (10+ Others)

Key Topics Covered:

1: Executive Summary

2: Introduction To Molecular Diagnostics

3: Molecular Diagnostics In Healthcare

4: Market Analysis

5: Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/wlrqnm/infectious

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl